Effect of smoking on serum RANKL and OPG in sex, age and clinically matched supportive-therapy periodontitis patients

Methods: The serum concentrations of receptor activator of nuclear factor κB ligand (RANKL) and osteoprotegerin (OPG) in age‐ and sex‐matched groups of smokers and non‐smokers with almost identical levels of periodontal disease were determined by an enzyme‐linked immunosorbent assay (ELISA). We ensu...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical periodontology Vol. 34; no. 4; pp. 271 - 277
Main Authors Lappin, David F., Sherrabeh, Sakhr, Jenkins, William M. M., Macpherson, Lorna M. D.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.04.2007
Blackwell
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Methods: The serum concentrations of receptor activator of nuclear factor κB ligand (RANKL) and osteoprotegerin (OPG) in age‐ and sex‐matched groups of smokers and non‐smokers with almost identical levels of periodontal disease were determined by an enzyme‐linked immunosorbent assay (ELISA). We ensured that the 35 smokers were gender, age and clinically matched with a group of 35 non‐smokers (confirmed by cotinine immunoassay) from the same population of maintained patients with susceptibility to periodontitis. Results: Cigarette smoker patients tended to have lower serum concentrations of RANKL and OPG than non‐smoker patients. While no statistically significant difference was observed for RANKL, there were significant differences in the median serum concentration of OPG (smokers 23.76 pM, non‐smokers 59.28 pM) and the ratio of serum concentrations of RANKL and OPG. Concentrations of OPG in the smoker patients also had a statistically significant negative correlation with tobacco consumption. Conclusion: Bone loss in smoker‐related periodontitis patients may be partially explained by suppression of OPG production.
Bibliography:ark:/67375/WNG-X91598QJ-G
ArticleID:JCPE1048
istex:A1B16D6FFB63C9C6D0A07DD58DC1A9442E8DB746
The authors declare that they have no conflict of interest.
The authors would like to acknowledge the Medical Faculty University of Glasgow. Dr. Sherrabeh was in receipt of a Scholarship from the University of Aleppo, Syria.
Conflict of interest and source of funding statement
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0303-6979
1600-051X
DOI:10.1111/j.1600-051X.2007.01048.x